Plant based covid 19 plant based vaccine approved in canada. Medigachoś tech takes the idea of traditional vaccine manufacturing based on using eggs to produce viruses and instead uses living plants as the bioreactor that produces a protein particle that mimics the target virus .
Covifenz represents the first Covid 19 vaccine using plant based vaccine , as well as being medicagoś first approved vaccine and the first authorized covid 19 vaccine developed by a canadian based company.
Founded in 1999 , Quebec cityś medicago is a pioneer of plant derived therapeutics. Its research started with an influenza vaccine candidate but pivoted to covid 19 at the start of the pandemic. The recombinant , adjuvanted vaccine is indicated in canada for active immunization to prevent coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus to in individuals 18 thru 64 years of age.
Covifenz uses coronavirus like particle technology with the vaccine composed of recombinant spike glycoprotein expressed as virus like particles co administered with GSKś pandemic adjuvant . The vaccination regiment calls for 2 doses given intramuscularly 21 days apart. The vaccine is refrigerator stable.
Comentários